- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01764984
Bone Mineral Density Changes Under Two Tibial Components in Total Knee Arthroplasty
February 2, 2015 updated by: Étienne Belzile, CHU de Quebec-Universite Laval
Randomized Clinical Evaluation of Bone Mineral Density Changes Under Non-cemented Trabecular Metal Tibial Component and Cemented Titanium Controls.
Osteoarthritis is a progressive disease afflicting to two thirds of Americans.
Today, an estimated 43 million individuals have arthritis.
By 2020, more than 59.4 million Americans will be affected by the disease.
Despite the relative good track record of total knee replacement, it remains a biomedical device that can fail over time.
A recent study looking at the current mechanisms of total knee replacement failures, listed polyethylene wear and osteolysis around implants.
The material used for polyethylene insert as well as the conformity of articular surface of implants has been modified to decrease wear.
While introducing modularity, the usage of metal backing in tibial base plates became obvious as it offered better stress distribution to the proximal tibial bone.
However, it introduced other modes of failures.
Micromotion has been demonstrated between the metal backing and the tibial liner, and produced backside polyethylene wear in 44% of implants at retrieval for revision.
Factor influencing the surgeon's choice of implant include: reproductibility and longevity of results, technical difficulty of implantation, cost, and impact on bone stock.
The modulus of elasticity of the tibial base plate has a direct effect on periprosthetic bone biology.
Studies have described a significant decrease in postoperative Bone mineral density (BMD), adjacent to the implants, after total knee replacement.
No study, to our knowledge, has looked at BMD in vivo after total knee replacement comparing different tibial base plate designs.
Direct effect of changes in design on overall implant survival can be studied with randomized clinical trials isolating specific variables.
No randomized clinical trial has looked at tibial insert stiffness and modularity, and it effect on bone density changes, synovitis, osteolysis or survivorship.
In order to isolate stiffness and modularity as study variables, one would aim at randomizing an homogenous patient population undergoing total knee arthroplasty with implants of similar articular geometry designs with different tibial insert modularity and stiffness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Number of patients: 80 Ages: 55 - 75 years old Sex: male and female Race: all
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H1T 2M4
- Hopital Maisonneuve Rosemont
-
Montreal, Quebec, Canada
- Hopital Du Sacre-Coeur
-
Quebec city, Quebec, Canada, G1R 2J6
- Centre Hospitalier Universitaire de Quebec
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Tri-compartmental knee arthrosis
- 55 to 75 years of age
- Stable health condition
Exclusion Criteria:
- Inflammatory arthritis
- Osteonecrosis
- Infection
- Amputation (AK or BK)
- Biphosphonates
- Metal in the proximal tibia (25cm)
- History of fracture or osteotomy
- Ligament instability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Trabecular metal
Primary Total Knee Arthroplasty is performed with a non cemented trabecular metal tibial baseplate.
|
Total knee arthroplasty using parapatellar approach and postero-stabilized implants.
Other Names:
|
|
ACTIVE_COMPARATOR: Titanium
Primary total knee arthroplasty is performed with cemented titanium traditional tibial base plate
|
Total knee arthroplasty using parapatellar approach and postero-stabilized implants.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Bone Mineral Density (%) from baseline initial value
Time Frame: post-operative 7 to 10 days, 6,12,24 months
|
Evaluation of Bone Mineral Density using dual energy x-ray absorptiometry (DEXA) scan under tibial base plate implant after Total knee arthroplasty.
|
post-operative 7 to 10 days, 6,12,24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Western Ontario & McMAster University Osteoarthritis sCore (WOMAC)change in time.
Time Frame: Pre-operative, 6,12,24,60 months
|
Standardized clinical evaluation instrument specific to Total knee arthroplasty population.
|
Pre-operative, 6,12,24,60 months
|
|
number of study subject with implant loosening
Time Frame: 12, 24, 60 months
|
Radiological evaluation of implant loosening according to Radiographic Knee Society Score at follow-up after total knee arthroplasty.
|
12, 24, 60 months
|
|
Knee injury and Osteoarthritis Outcome Score (KOOS) change in time.
Time Frame: pre-operative, 6,12,24,60 months
|
Standardized clinical outcome instruments specific to total knee arthroplasty population.
|
pre-operative, 6,12,24,60 months
|
|
SF-36 score
Time Frame: Pre-operative, 12,24,60 months
|
Standardized General health evaluation and quality of life measuring instrument.
|
Pre-operative, 12,24,60 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Etienne L Belzile, MD, Centre hospitalier universitaire de Québec - Université Laval
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2005
Primary Completion (ACTUAL)
September 1, 2009
Study Completion (ACTUAL)
January 1, 2015
Study Registration Dates
First Submitted
February 17, 2012
First Submitted That Met QC Criteria
January 8, 2013
First Posted (ESTIMATE)
January 10, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
February 4, 2015
Last Update Submitted That Met QC Criteria
February 2, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5.5.04.12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Unilateral Primary Osteoarthritis of Knee
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaCompletedUnilateral Primary Osteoarthritis of KneeFrance
-
Barbara A RakelCompletedUnilateral Primary Osteoarthritis of Knee | Primary Osteoarthritis of Knee NosUnited States
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
University of Sao Paulo General HospitalUnknownUnilateral Primary Osteoarthritis of KneeBrazil
-
Ministry of Health, MalaysiaUnknownUnilateral Primary Osteoarthritis of KneeMalaysia
-
University Hospital, RouenNot yet recruitingUnilateral Primary Osteoarthritis, Left KneeFrance
-
CrystalGenomics, Inc.CompletedLocalized Primary Osteoarthritis of Hip | Localized Primary Osteoarthritis of KneeKorea, Republic of
-
Virtua Health, Inc.TerminatedPrimary Osteoarthritis of Knee NosUnited States
-
University of OxfordUniversity of Copenhagen; Zimmer BiometUnknownPrimary Osteoarthritis of Knee NosUnited Kingdom
-
Mahidol UniversityCompletedPrimary Osteoarthritis of Knee NosThailand
Clinical Trials on Total knee arthroplasty
-
Satakunta Central HospitalNot yet recruiting
-
University of PittsburghRecruiting
-
Technische Universität DresdenMathys Ltd BettlachCompletedKnee Osteoarthritis
-
Technische Universität DresdenActive, not recruiting
-
Jesus Moreta SuarezActive, not recruiting
-
Chang Gung Memorial HospitalUnknownComputer-assisted Navigation Versus Conventional Total Knee ReplacementTaiwan
-
Smith & Nephew, Inc.TerminatedDegenerative Arthritis of KneeUnited States, Australia
-
Istituto Ortopedico RizzoliRecruitingKnee Arthroplasty, TotalItaly
-
Technische Universität DresdenAesculap AGCompletedOsteoarthritis | Metal Ion LevelsGermany
-
University of ConnecticutCompletedOsteo Arthritis Knee | Hip Osteoarthritis | Protein-Energy Malnutrition | Orthopedic | Energy Malnutrition ProteinUnited States